ADMA Biologics, Inc.ADMANASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Percentile
P100
Near historical high
vs 2Y Ago
38.6x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$197.86M+34.0%
2024$147.69M+2784.6%
2023$5.12M+113.0%
2022$-39.51M+25.6%
2021$-53.09M+11.2%
2020$-59.82M-66.0%
2019$-36.03M+36.5%
2018$-56.77M-44.4%
2017$-39.31M-133.9%
2016$-16.81M-